Fundraising FoxNivagen Pharmaceuticals
Sacramento, US · Delaware corporation · 1 known investors
Find your way into Nivagen Pharmaceuticals
Sign up to see every warm intro you have to Nivagen Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nivagen Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SD
Sharad DadbhawalaNamed on SEC filing
JS
Jwalant ShuklaNamed on SEC filing
BS
Bikram SinghNamed on SEC filing
AS
Ashish SevakNamed on SEC filing
Investors · 1
Telegraph Hill PartnersreportedSan Francisco · $2M – $8M
How we know: a partner's Signal profile · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$31M disclosed across 3 rounds · 2017–2023
▶$5MraisedAug 2023 · 1 investors · PharmaceuticalsRule 506(b)
▶$5MraisedAug 2023 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dasaradhi LakkarajuExecutive Officer
- Jaswinder MatharuDirector
- Gopal PatelExecutive Officer
- Jwalant ShuklaExecutive Officer, Director
- Rob C. HartDirector
- Ashish SevakDirector
- Praneel DeoExecutive Officer
- Michael KulperDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16MraisedMay 2020 · 7 investors · PharmaceuticalsRule 506(b)
▶$16MraisedMay 2020 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jaswinder MatharuDirector
- Ashish SevakDirector
- Bikramjit SinghDirector
- Rob C. HartDirector
- Jwalant ShuklaExecutive Officer, Director
- Offering amount
- $16M
- Amount sold
- $16M
- Minimum investment
- $107.4K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedSep 2017 · 1 investors · PharmaceuticalsRule 506(b)
▶$10MraisedSep 2017 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sharad DadbhawalaDirector
- Jwalant ShuklaExecutive Officer, Director
- Bikram SinghDirector
- Ashish SevakDirector
- Offering amount
- $10M
- Amount sold
- $10M
- Minimum investment
- $10M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Nivagen Pharmaceuticals's investors?
- Nivagen Pharmaceuticals's investors include Telegraph Hill Partners.
- How much funding has Nivagen Pharmaceuticals raised?
- Nivagen Pharmaceuticals has disclosed $31M raised across 3 rounds.
- Where is Nivagen Pharmaceuticals headquartered?
- Nivagen Pharmaceuticals is headquartered in Sacramento, US.